publication venue for
- Biomarker-Driven Radiation Therapy Dose Reduction after Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer 2024
- Pembrolizumab and Cabozantinib in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma (RMHNSCC): 2-year Long Term Survival Update with Biomarker Analysis 2024
- Predictors of Occult Nodal Involvement in Clinically Node Negative Primary Parotid Carcinoma: An Updated NCDB Analysis 2024
- Institutional Comparison between Radiation with Concurrent Cisplatin Versus Carboplatin/paclitaxel for Squamous Cell Carcinoma of the Head and Neck (SCCHN) 2022
- CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) - Toxicity and Quality of Life (QoL) Results 2021
- Feasibility of Portable Audiometry for Ototoxicity Monitoring in a Radiation Oncology Clinic for Head and Neck Cancer Patients Receiving Cisplatin-Based Chemoradiotherapy 2020
- Definitive Management of Early Stage Oropharyngeal Carcinoma: A Comparison of Long Term Outcomes Following Transoral Surgery or Definitive Chemoradiation 2019
- Gender Differences in Radiation Therapy Effects in Male and Female Patients With Head and Neck Cancer 2018
- Planned Observational Study of Hearing Loss and the Effects of Statin Drugs in Head and Neck Squamous Cell Carcinoma Patients Treated With Chemoradiation 2018
- Quality of Life differences in Male and Female Patients with Head and Neck Cancer 2018
- Early T Stage Salivary Duct Carcinoma: Outcomes and Implications 2016